Patient Contoured Implant-PEEK (PCI-PEEK)— 510(k) K151382

Name: FDA 510(k) clearance K151382
Creator: U.S. Food and Drug Administration
Published: 2015-11-09

Substantially Equivalent

KLS Martin L.P.

FDA 510(k) clearance K151382 for Patient Contoured Implant-PEEK (PCI-PEEK), Substantially Equivalent on 2015-11-09. Applicant: KLS Martin L.P.. Device class: 2.

Clearance details

Applicant: KLS Martin L.P.
Product code: Code GXN
Device class: Class 2
Regulation: 21 CFR 882.5330
Advisory panel: Neurology
Date received: 2015-05-22
Decision date: 2015-11-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Jacksonville, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GXN

view all

K260709 — ClearFit Ti Ring 14mm (171750) +4 more2026-06-25
K253116 — 3D MAC Titanium Cranial Plate (TCP) System2026-06-18
K252251 — EASYMADE-TI2026-04-09
K252958 — METICULY Patient-specific titanium mesh implant2026-01-14
K243715 — Synthes Patient Specific Implants2025-11-12

More clearances from KLS Martin L.P.

view all

K260137 — KLS Martin IPS Oral-Max Implants - MR Conditional +3 more2026-08-17
K253660 — KLS Martin Pure Pectus System2026-02-20
K254162 — KLS Martin Ixos System2026-02-20
K250988 — KLS Martin Pure Pectus System2025-12-11
K250865 — KLS Martin IPS Forearm System2025-11-14

Adverse events under product code GXN

product code GXN

Injury: 208
Total: 208

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.